Irritable Bowel Syndrome. Irritable Bowel Syndrome
Conditions
Interventions
Intervention group: Mesalamine 2 gram daily + bismuth 120 mg daily.
Treatment - Drugs
Intervention group: Mesalamine 2 gram daily + bismuth 120 mg daily
Sponsors
Vice Chancellor for Research and Technology Development, Ahvaz Jondishapur University of Medical Sci
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: symptomatic patients more than 3 months; a normal colonoscopy; rule out celiac in patients; the patient's symptoms did not improve despite the use of conventional regimens for a year. Exclusion criteria: pregnancy or lactation; history of abdominal surgery; opioid analgesics; nonsteroidal anti inflammatory drugs; long term use of antibiotics; history of renal failure; severe liver disease; a history of hypersensitivity to salicylates; being diagnosed with a serious illness.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bloating. Timepoint: At first, second and fourth month of the study. Method of measurement: Patient assessment conducted by questionnaire.;Frequency of daily defecation. Timepoint: At first, second and fourth month of the study. Method of measurement: Patient assessment conducted by questionnaire.;Severity of abdominal pain. Timepoint: At first, second and fourth month of the study. Method of measurement: Patient assessment conducted by questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vomiting. Timepoint: At first, second and fourth month of the study. Method of measurement: Patient assessment conducted by questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Atefeh Roumi
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed